Pharmacogenetic characterization of indacaterol, a novel β(2)-adrenoceptor agonist

BACKGROUND AND PURPOSE: Indacaterol is a novel β(2)-adrenoceptor agonist in development for the treatment of chronic obstructive pulmonary disease. The aim of this study was to investigate the comparative pharmacology of indacaterol in recombinant cells expressing the common polymorphic variants of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sayers, I, Hawley, J, Stewart, CE, Billington, CK, Henry, A, Leighton-Davies, JR, Charlton, SJ, Hall, IP
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2009
Teme:
Research Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2795231/
https://ncbi.nlm.nih.gov/pubmed/19422388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2009.00224.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items